BioStem Technologies, Inc. (BSEM) vs Microbot Medical Inc. (MBOT)
A side-by-side comparison of BioStem Technologies, Inc. and Microbot Medical Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BSEM
BioStem Technologies, Inc.
$2.57HealthcareDelayed quote: Oct 6, 2026, 2:44 PM EDT
MBOT
Microbot Medical Inc.
$1.09HealthcareDelayed quote: Oct 6, 2026, 2:39 PM EDT
Total return — BSEM vs MBOT
growth of $100 · dividends reinvested · last 10yBSEM -72.4% (-12.1%/yr)MBOT -99.4% (-39.8%/yr)BSEM compounded faster over this window
Log scale — wide-divergence pair
BSEM MBOT
BSEM vs MBOT: by the numbers
- •MBOT is the larger company ($49M vs $44M market cap).
- •Both run net losses; BSEM's is the smaller (-13.86% vs -4722.25% net margin).
Metrics side by side
Valuation
| Metric | BSEM | MBOT |
|---|---|---|
| P/S ratio | N/A | 142.90 |
| P/B ratio | 1.58 | 0.72 |
Profitability
| Metric | BSEM | MBOT |
|---|---|---|
| Gross margin | 93.13% | 0.00% |
| Operating margin | -1.45% | 0.00% |
| Net margin | -13.86% | -4722.25% |
| ROE | -102.45% | -23.70% |
| ROIC | -80.92% | -26.51% |
Growth (annualized)
| Metric | BSEM | MBOT |
|---|---|---|
| Total return CAGR (5Y) | 15.72% | -31.63% |
Frequently asked
- How have BSEM and MBOT total returns compared?
- Over the past 10 years, BSEM delivered -12.08% and MBOT delivered -39.57% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.